Skip to content

CIK 0001600847

GMDA Gamida Cell Ltd.

Insider trading from SEC Form 4. Last filing Feb 2, 2024.

In brief

Gamida Cell Ltd. (GMDA) has 10 SEC Form 4 filings on file from 6 insiders, the latest filed on Feb 2, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company

Signals

Open-market buys and sells at Gamida Cell Ltd., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 19 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jan 31, 2024Ivan M. Borrello
director
AGrant or award
Ordinary Shares
+200,000$0.00$0232,300Feb 2, 2024
Jan 31, 2024Julian Adams
director
AGrant or award
Ordinary Shares
+200,000$0.00$0423,750Feb 2, 2024
Oct 19, 2023Shawn Tomasello
director
AGrant or award
Share Option (Right to Buy)derivative
+17,000$0.00$017,000Oct 20, 2023
Oct 19, 2023Shawn Tomasello
director
AGrant or award
Ordinary Shares
+28,300$0.00$041,977Oct 20, 2023
Oct 19, 2023Stephen T Wills
director
AGrant or award
Ordinary Shares
+28,300$0.00$041,977Oct 20, 2023
Oct 19, 2023Kenneth I Moch
director
AGrant or award
Ordinary Shares
+28,300$0.00$032,300Oct 20, 2023
Oct 19, 2023Abigail L. Jenkins
President and CEO
AGrant or award
Ordinary Shares
+250,000$0.00$0266,129Oct 20, 2023
Oct 19, 2023Ivan M. Borrello
director
AGrant or award
Ordinary Shares
+28,300$0.00$032,300Oct 20, 2023
Oct 19, 2023Julian Adams
director
AGrant or award
Ordinary Shares
+28,300$0.00$0223,750Oct 20, 2023
Oct 19, 2023Abigail L. Jenkins
President and CEO
AGrant or award
Ordinary Shares
+109,013$0.00$0375,142Oct 20, 2023
Oct 19, 2023Ivan M. Borrello
director
AGrant or award
Share Option (Right to Buy)derivative
+56,600$0.00$056,600Oct 20, 2023
Oct 19, 2023Abigail L. Jenkins
President and CEO
AGrant or award
Employee Share Option (Right to Buy)derivative
+1,000,000$0.00$01,000,000Oct 20, 2023
Oct 19, 2023Julian Adams
director
AGrant or award
Share Option (Right to Buy)derivative
+56,600$0.00$056,600Oct 20, 2023
Oct 19, 2023Kenneth I Moch
director
AGrant or award
Share Option (Right to Buy)derivative
+56,600$0.00$056,600Oct 20, 2023
Oct 19, 2023Stephen T Wills
director
AGrant or award
Ordinary Shares
+14,200$0.00$056,177Oct 20, 2023
Oct 19, 2023Abigail L. Jenkins
President and CEO
AGrant or award
Employee Share Option (Right to Buy)derivative
+217,954$0.00$0217,954Oct 20, 2023
Oct 19, 2023Shawn Tomasello
director
AGrant or award
Share Option (Right to Buy)derivative
+56,600$0.00$056,600Oct 20, 2023
Oct 19, 2023Stephen T Wills
director
AGrant or award
Share Option (Right to Buy)derivative
+56,600$0.00$056,600Oct 20, 2023
Oct 19, 2023Stephen T Wills
director
AGrant or award
Share Option (Right to Buy)derivative
+28,300$0.00$028,300Oct 20, 2023

Insiders

Everyone who has filed a Form 4 here.

Questions about GMDA

Answered from the filings on this page, as of the latest one.

Are insiders buying GMDA?

No. In the last 90 days no insider at Gamida Cell Ltd. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade GMDA on the open market?

No open-market trade has been scored at Gamida Cell Ltd.. The latest Form 4 on file was filed on Feb 2, 2024 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Gamida Cell Ltd.?

6 people have filed a Form 4 at Gamida Cell Ltd., among them Julian Adams (director), Ivan M. Borrello (director), Abigail L. Jenkins (President and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

GMDA insider trading: Gamida Cell Ltd. | InsiderTell